This company has shut down. BioPhy is no longer operating — its last tracked round was a Venture - Series Unknown in 2025.
Explore the Startup GraveyardBioPhy's patent pending AI brings predictability and quantifiable risk to drug development
BioPhy has raised $6.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
BioPhy's investors include Metrodora Ventures, Audere Capital, TRCM Fund, Jeffrey Marrazzo.
BioPhy is headquartered in Philadelphia, United States.
BioPhy's patent pending AI brings predictability and quantifiable risk to drug development
BioPhy is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioPhy — Funding & Investors." VCBacked, March 20, 2025, https://www.vcbacked.co/company/biophy. Accessed August 14, 2026.
VCBacked. (2025). BioPhy — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/biophy
{{cite web |title=BioPhy — Funding & Investors |url=https://www.vcbacked.co/company/biophy |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated